Childhood-onset dystonia-causing KMT2B variants result in a distinctive genomic hypermethylation profile
暂无分享,去创建一个
A. Capuano | M. Tartaglia | E. Agolini | E. Miele | M. Andreani | B. Sadikovic | M. Bedeschi | P. Prontera | B. Garavaglia | R. Gavrilova | V. Leuzzi | G. Zorzi | P. Soliveri | A. Ciolfi | M. Niceta | F. Invernizzi | M. Iascone | R. Olson | S. Galosi | M. Garibaldi | S. Pizzi | Laura E. Schultz-Rogers | L. Travaglini | C. Panteghini | L. Pedace | Aidin Foroutan | C. Reale | Chiara Reale | Lucia Pedace
[1] Meghan C Towne,et al. SPEN haploinsufficiency causes a neurodevelopmental disorder overlapping proximal 1p36 deletion syndrome with an episignature of X chromosomes in females. , 2021, American journal of human genetics.
[2] R. Stevenson,et al. Clinical epigenomics: genome-wide DNA methylation analysis for the diagnosis of Mendelian disorders , 2021, Genetics in Medicine.
[3] Kelly A. Mills,et al. KMT2B-related disorders: expansion of the phenotypic spectrum and long-term efficacy of deep brain stimulation. , 2020, Brain : a journal of neurology.
[4] A. Oshlack,et al. Gene set enrichment analysis for genome-wide DNA methylation data , 2020, Genome Biology.
[5] M. Shaw,et al. Evaluation of DNA Methylation Episignatures for Diagnosis and Phenotype Correlations in 42 Mendelian Neurodevelopmental Disorders. , 2020, American journal of human genetics.
[6] B. Dallapiccola,et al. Frameshift mutations at the C-terminus of HIST1H1E result in a specific DNA hypomethylation signature , 2020, Clinical epigenetics.
[7] J. Winkelmann,et al. Update on KMT2B-Related Dystonia , 2019, Current Neurology and Neuroscience Reports.
[8] Lea M. Starita,et al. Recommendations for application of the functional evidence PS3/BS3 criterion using the ACMG/AMP sequence variant interpretation framework , 2019, Genome Medicine.
[9] Jing Wang,et al. WebGestalt 2019: gene set analysis toolkit with revamped UIs and APIs , 2019, Nucleic Acids Res..
[10] I. Krantz,et al. Diagnostic Utility of Genome-wide DNA Methylation Testing in Genetically Unsolved Individuals with Suspected Hereditary Conditions. , 2019, American journal of human genetics.
[11] Ryan L. Collins,et al. The mutational constraint spectrum quantified from variation in 141,456 humans , 2020, Nature.
[12] G. Vriend,et al. MetaDome: Pathogenicity analysis of genetic variants through aggregation of homologous human protein domains , 2019, bioRxiv.
[13] A. F. Stewart,et al. KMT2B Is Selectively Required for Neuronal Transdifferentiation, and Its Loss Exposes Dystonia Candidate Genes , 2018, Cell reports.
[14] Brent S. Pedersen,et al. A map of constrained coding regions in the human genome , 2017, bioRxiv.
[15] Brent S. Pedersen,et al. GIGGLE: a search engine for large-scale integrated genome analysis , 2017, Nature Methods.
[16] T. Strom,et al. KMT2B rare missense variants in generalized dystonia , 2017, Movement disorders : official journal of the Movement Disorder Society.
[17] K. Lohmann,et al. Update on the Genetics of Dystonia , 2017, Current Neurology and Neuroscience Reports.
[18] Hagai Bergman,et al. Mutations in the histone methyltransferase gene KMT2B cause complex early-onset dystonia , 2016, Nature Genetics.
[19] W. Poewe,et al. Haploinsufficiency of KMT2B, Encoding the Lysine-Specific Histone Methyltransferase 2B, Results in Early-Onset Generalized Dystonia. , 2016, American journal of human genetics.
[20] Christina N. Vallianatos,et al. Disrupted intricacy of histone H3K4 methylation in neurodevelopmental disorders. , 2015, Epigenomics.
[21] Michael Q. Zhang,et al. Integrative analysis of 111 reference human epigenomes , 2015, Nature.
[22] Peter L Molloy,et al. De novo identification of differentially methylated regions in the human genome , 2015, Epigenetics & Chromatin.
[23] Matthew E. Ritchie,et al. limma powers differential expression analyses for RNA-sequencing and microarray studies , 2015, Nucleic acids research.
[24] Erica Y. Shen,et al. Regulation of histone H3K4 methylation in brain development and disease , 2014, Philosophical Transactions of the Royal Society B: Biological Sciences.
[25] Rafael A. Irizarry,et al. Minfi: a flexible and comprehensive Bioconductor package for the analysis of Infinium DNA methylation microarrays , 2014, Bioinform..
[26] J. Shendure,et al. A general framework for estimating the relative pathogenicity of human genetic variants , 2014, Nature Genetics.
[27] A. F. Stewart,et al. Mll2 is required for H3K4 trimethylation on bivalent promoters in embryonic stem cells, whereas Mll1 is redundant , 2014, Development.
[28] Ruth Pidsley,et al. A data-driven approach to preprocessing Illumina 450K methylation array data , 2013, BMC Genomics.
[29] J. Whetstine,et al. Histone lysine methylation dynamics: establishment, regulation, and biological impact. , 2012, Molecular cell.
[30] Devin C. Koestler,et al. DNA methylation arrays as surrogate measures of cell mixture distribution , 2012, BMC Bioinformatics.
[31] E. Feierstein,et al. DNA Methylation of the First Exon Is Tightly Linked to Transcriptional Silencing , 2011, PloS one.
[32] Aaron R. Quinlan,et al. BIOINFORMATICS APPLICATIONS NOTE , 2022 .
[33] Madeleine P. Ball,et al. Corrigendum: Targeted and genome-scale strategies reveal gene-body methylation signatures in human cells , 2009, Nature Biotechnology.
[34] Israel Steinfeld,et al. Developmental programming of CpG island methylation profiles in the human genome , 2009, Nature Structural &Molecular Biology.
[35] Nathaniel D. Heintzman,et al. Distinct and predictive chromatin signatures of transcriptional promoters and enhancers in the human genome , 2007, Nature Genetics.
[36] Shirley A. Miller,et al. A simple salting out procedure for extracting DNA from human nucleated cells. , 1988, Nucleic acids research.
[37] S. Baylin,et al. A KDM5 Inhibitor Increases Global H3K4 Trimethylation Occupancy and Enhances the Biological Efficacy of 5-Aza-2'-Deoxycytidine. , 2018, Cancer research.
[38] Hilde van der Togt,et al. Publisher's Note , 2003, J. Netw. Comput. Appl..